Assenagon Asset Management S.A. Lowers Stock Holdings in Oscar Health, Inc. (NYSE:OSCR)

Assenagon Asset Management S.A. lowered its position in shares of Oscar Health, Inc. (NYSE:OSCR) by 52.4% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 973,791 shares of the company’s stock after selling 1,072,255 shares during the period. Assenagon Asset Management S.A. owned 0.40% of Oscar Health worth $20,654,000 as of its most recent SEC filing.

Several other hedge funds also recently bought and sold shares of the company. Vanguard Group Inc. boosted its holdings in Oscar Health by 0.8% in the 4th quarter. Vanguard Group Inc. now owns 14,244,912 shares of the company’s stock valued at $130,341,000 after purchasing an additional 116,978 shares during the period. Allspring Global Investments Holdings LLC purchased a new position in Oscar Health during the first quarter worth about $4,117,000. Quantbot Technologies LP increased its stake in Oscar Health by 435.5% in the 1st quarter. Quantbot Technologies LP now owns 14,495 shares of the company’s stock worth $216,000 after acquiring an additional 11,788 shares during the last quarter. Oppenheimer & Co. Inc. raised its holdings in shares of Oscar Health by 20.8% in the 1st quarter. Oppenheimer & Co. Inc. now owns 19,450 shares of the company’s stock valued at $289,000 after acquiring an additional 3,350 shares in the last quarter. Finally, Avalon Trust Co purchased a new stake in shares of Oscar Health in the 1st quarter valued at about $69,000. Hedge funds and other institutional investors own 75.70% of the company’s stock.

Wall Street Analyst Weigh In

Several research analysts recently weighed in on OSCR shares. Piper Sandler restated an “overweight” rating and issued a $28.00 price objective on shares of Oscar Health in a research report on Tuesday, September 10th. UBS Group began coverage on shares of Oscar Health in a research report on Monday, October 7th. They set a “neutral” rating and a $23.00 price objective on the stock. Three analysts have rated the stock with a hold rating, four have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $24.00.

Oscar Health Trading Down 5.9 %

Shares of OSCR opened at $16.19 on Friday. The firm has a market cap of $3.92 billion, a price-to-earnings ratio of -124.53, a PEG ratio of 31.76 and a beta of 1.62. The company has a debt-to-equity ratio of 0.26, a quick ratio of 0.91 and a current ratio of 0.91. The firm has a 50 day moving average price of $18.80 and a 200-day moving average price of $18.32. Oscar Health, Inc. has a fifty-two week low of $4.72 and a fifty-two week high of $23.79.

Oscar Health (NYSE:OSCR) last posted its earnings results on Wednesday, August 7th. The company reported $0.20 earnings per share for the quarter, topping analysts’ consensus estimates of $0.16 by $0.04. The company had revenue of $2.20 billion during the quarter, compared to analyst estimates of $2.13 billion. Oscar Health had a net margin of 0.25% and a return on equity of 1.86%. Oscar Health’s revenue for the quarter was up 44.6% on a year-over-year basis. During the same period in the prior year, the business posted ($0.07) earnings per share. As a group, equities research analysts forecast that Oscar Health, Inc. will post 0.01 earnings per share for the current year.

Insiders Place Their Bets

In other news, CFO Richard Scott Blackley sold 68,978 shares of the business’s stock in a transaction that occurred on Tuesday, September 3rd. The stock was sold at an average price of $17.99, for a total transaction of $1,240,914.22. Following the transaction, the chief financial officer now directly owns 884,213 shares of the company’s stock, valued at approximately $15,906,991.87. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. In other news, CFO Richard Scott Blackley sold 68,978 shares of the firm’s stock in a transaction dated Tuesday, September 3rd. The shares were sold at an average price of $17.99, for a total value of $1,240,914.22. Following the completion of the sale, the chief financial officer now directly owns 884,213 shares of the company’s stock, valued at approximately $15,906,991.87. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, CAO Victoria Baltrus sold 4,226 shares of the business’s stock in a transaction dated Tuesday, September 3rd. The shares were sold at an average price of $17.99, for a total transaction of $76,025.74. Following the transaction, the chief accounting officer now owns 140,648 shares in the company, valued at $2,530,257.52. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders sold 169,569 shares of company stock worth $3,007,069. 25.11% of the stock is currently owned by company insiders.

Oscar Health Company Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.